[HTML][HTML] Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: an 8-year retrospective study
R Wang, Y Zhang, J Tan, G Zhang, R Zhang, W Zheng… - Medicine, 2017 - journals.lww.com
To assess the efficacy of radioiodine therapy (RIT) and investigate the prognostic factors for
patients with pulmonary metastasis secondary to differentiated thyroid carcinoma (DTC) …
patients with pulmonary metastasis secondary to differentiated thyroid carcinoma (DTC) …
Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors
HJ Song, ZL Qiu, CT Shen, WJ Wei… - European Journal of …, 2015 - academic.oup.com
Context Data from a large cohort of patients with pulmonary metastases from differentiated
thyroid cancer (DTC) were retrospectively analyzed. Objective To assess the effect of …
thyroid cancer (DTC) were retrospectively analyzed. Objective To assess the effect of …
[HTML][HTML] Analysis of the clinical factors affecting excellent response of Iodine-131 treatment for pulmonary metastases from differentiated thyroid cancer
XY Wu, B Li, J Zhang, LL Duan, BX Hu, YJ Gao - Heliyon, 2023 - cell.com
Abstract Background Iodiene-131 (131 I) treatment is the primary therapeutic approach for
imaging 131 I-avid pulmonary metastases. The response to radioiodine (RAI) treatment is an …
imaging 131 I-avid pulmonary metastases. The response to radioiodine (RAI) treatment is an …
[HTML][HTML] Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current …
X Zhang, DS Liu, ZS Luan, F Zhang, XH Liu… - Clinical and …, 2018 - Springer
Background Radioiodine therapy (RAI) after total or near-total thyroidectomy is a
recommended treatment for patients with pulmonary metastasis from differentiated thyroid …
recommended treatment for patients with pulmonary metastasis from differentiated thyroid …
Difference of clinical and radiological characteristics according to radioiodine avidity in pulmonary metastases of differentiated thyroid cancer
Purpose To evaluate differences in clinical, radiological and laboratory findings between
pulmonary metastasis with and without radioiodine avidity in thyroidectomized differentiated …
pulmonary metastasis with and without radioiodine avidity in thyroidectomized differentiated …
Evaluation of prognostic factors associated with differentiated thyroid carcinoma with pulmonary metastasis
Background Because one of the major sites for metastasis of thyroid cancers is the lung,
studying the pattern of pulmonary metastasis may provide useful information for the effective …
studying the pattern of pulmonary metastasis may provide useful information for the effective …
Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive …
ZL Qiu, CT Shen, QY Luo - Thyroid, 2015 - liebertpub.com
Background: Hyperfunctioning distant metastasis (HFDM) from differentiated thyroid cancer
(DTC) is a rare entity. This study aimed to assess the outcomes of DTC patients presenting …
(DTC) is a rare entity. This study aimed to assess the outcomes of DTC patients presenting …
[HTML][HTML] Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed …
B Long, M Yang, Z Yang, H Yi, L Li - Oncology Letters, 2016 - spandidos-publications.com
Radioiodine therapy (RAI) has proven effective for the treatment of patients exhibiting
differentiated thyroid cancer (DTC) with pulmonary metastases. However, the early detection …
differentiated thyroid cancer (DTC) with pulmonary metastases. However, the early detection …
Radioactive iodine therapy in patients with thyroid carcinoma with distant metastases: a SEER-based study
C Li, Q Wu, S Sun - Cancer control, 2020 - journals.sagepub.com
Distant metastasis (DM) is the dominant negative prognosis for thyroid carcinoma.
Radioactive iodine (RAI) therapy serves as an effective treatment for thyroid carcinoma …
Radioactive iodine (RAI) therapy serves as an effective treatment for thyroid carcinoma …
Risk factors for nonremission and progression-free survival after I-131 therapy in patients with lung metastasis from differentiated thyroid cancer: a single-institute …
P Chen, H Feng, W Ouyang, J Wu, J Wang, Y Sun… - Endocrine Practice, 2016 - Elsevier
Objective: Prognostic factors related to progression-free survival (PFS) have not received
much attention in the literature regarding iodine-131 (131 I) therapy for patients with …
much attention in the literature regarding iodine-131 (131 I) therapy for patients with …
相关搜索
- thyroid cancer pulmonary metastases
- prognostic factors pulmonary metastasis
- prognostic factors radioiodine therapy
- thyroid cancer radioiodine therapy
- pulmonary metastases radioiodine therapy
- retrospective analysis therapy in patients
- thyroid cancer prognostic factors
- thyroid cancer retrospective analysis
- meta analysis radioiodine therapy
- lung metastasis therapy in patients
- thyroid carcinoma iodine therapy
- lung metastasis retrospective analysis
- pulmonary metastases meta analysis
- outcomes in patients iodine therapy
- thyroid cancer remission in patients
- risk factors therapy in patients